Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L
Initial Focus on Acute Respiratory Distress Syndrome, including COVID-19 NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;...